Research News & Studies

Topics

<< < (2/290) > >>

[1] HIV gene therapy - AGT103-T

[2] Does Cannabis Use Impair Treatment Adherence?

[3] Lenacapavir capsid inhibitor (GS-6207) - CAPELLA trial

[4] Mosaico & Imbokodo HIV vaccine - HIV Vaccine Fails

[5] Daily PrEP is safe for the kidneys

[6] $1.3 Million Grant to Develop Interventions for Black Smokers With HIV

[7] State of HIV Cure Research as 2022 Comes to an End

[8] MSD/Merck’s once-weekly phase 2 study stopped - NNRTI MK-8507

[9] HIV Time to Viral Rebound After Interruption of Modern ART. (ACTG) A5345

Navigation

[0] Up one level

[#] Next page

[*] Previous page